• Western blot analysis of the lysates from COLO205 cells using B4GALNT1 antibody.
  • Western blot analysis of various cells using GM2/GD2 synthase Polyclonal Antibody

Anti-B4GALNT1 antibody (281-330 aa) (STJ93301)

SKU:
STJ93301

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Beta-1, 4 N-acetylgalactosaminyltransferase 1-galactosylglucosylceramide (281-330 aa) is suitable for use in Western Blot and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
ELISA 1:5000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: B4GALNT1
Gene ID: 2583
Uniprot ID: B4GN1_HUMAN
Immunogen Region: 281-330 aa
Specificity: GM2/GD2 synthase Polyclonal Antibody detects endogenous levels of GM2/GD2 synthase protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human B4GALNT1 at the amino acid range 281-330
Protein Name Beta-1 -4 N-Acetylgalactosaminyltransferase 1
(N-Acetylneuraminyl-Galactosylglucosylceramide
Gm2/Gd2 Synthase
Galnac-T
Database Links Reactome: R-HSA-1660662
Cellular Localisation Golgi Apparatus Membrane
Single-Pass Type Ii Membrane Protein
Alternative Antibody Names Anti-Beta-1 -4 N-Acetylgalactosaminyltransferase 1 antibody
Anti-(N-Acetylneuraminyl-Galactosylglucosylceramide antibody
Anti-Gm2/Gd2 Synthase antibody
Anti-Galnac-T antibody
Anti-B4GALNT1 antibody
Anti-GALGT antibody
Anti-SIAT2 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance